RaQualia Pharma, Inc. was recently spun off by drug maker Pfizer Inc , aims to go public by the first quarter of 2011, The company develops compounds for patient studies and sells drugs to pharmaceutical manufacturers. It also focuses on research for remedies in gastrointestinal, liver diseases, and pain in general areas. The company is based in Taketoyo-cho City, Japan.